Success Story: RFE Resolved, NIW Approved! Indian Scientist Reaches the Finish Line Strong with Our Firm’s Guidance
Client’s Testimonial:
“This is fantastic news! Thank you very much! Special thanks to my attorneys for their diligent support during the initial case preparation and the RFE response phase.”
On February 3rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Bioengineering (Approval Notice).
General Field: Bioengineering
Position at the Time of Case Filing: Scientist
Country of Origin: India
State of Residence at the time of filing: Massachusetts
Approval Notice Date: February 3rd, 2025
Processing Time: 10 months, 13 days
Case Summary:
We are pleased to share the success story of a bioengineering expert whose I-140 NIW (National Interest Waiver) petition was approved within 10 months and 13 days, even after receiving a Request for Evidence (RFE). This case underscores the national significance of advancing cell and gene therapy technologies to improve public health and address the burden of cancer, autoimmune conditions, and genetic disorders.
Our client holds a Ph.D. in engineering sciences and is currently employed as a bioengineering scientist. His proposed endeavor centers on developing state-of-the-art cell and gene therapies to establish cures for the most debilitating diseases, including cancer and traumatic brain injury. With a focus on enhancing therapeutic strategies, his research contributes directly to the U.S. goal of expanding biotechnology innovation, improving patient outcomes, and reducing the socioeconomic impact of major illnesses.
Filed under the EB-2 NIW category, the petition featured:
- 11 peer-reviewed journal articles,
- 2 abstracts,
- A total of 343 citations as per Google Scholar,
- At least 10 completed peer reviews for journals and conferences.
The petition demonstrated how our client’s research has already influenced investigations into cancer immunotherapy, skin disease treatment, and neurological injury recovery. His published work has appeared in some of the top scientific venues. In addition to this publication record, we highlighted his unique research contributions, including novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms. These innovations are being utilized by the broader scientific community and directly support critical national health and biotechnology goals.
We further strengthened the petition by noting that our client’s work has received funding from prestigious institutions such as the Department of Defense, the National Institutes of Health, Sanofi, and the Leo Foundation, underscoring the recognized value and national relevance of his work in curing complex diseases and improving therapeutic delivery mechanisms.
To support the petition, two letters of recommendation were submitted by respected experts in the field. These letters affirmed his influence on the development of novel cell therapies and his potential for continued impactful work.
“His distinctive array of skills sets him apart from his peers, firmly solidifying [Client’s] standing at the forefront of the bioengineering field.”
By clearly documenting the merit, importance, and feasibility of our client’s proposed endeavor, NAILG successfully secured a favorable outcome for this dedicated bioengineering professional. We look forward to his continued contributions to the advancement of transformative therapies that improve lives and reduce the national health burden.